News & Resources

Please insert excerpt info here.

Please insert excerpt info here.

In a tactic admission that it has misrepresented drug trial data in the past, GlaxoSmithKline announced this week it was going to open up portions of its research to the public, which is a first for a major drug company.    Researchers responded to the news with both skepticism and enthusiam.

Best Lawyers, the oldest and most respected peer-review publication in the legal profession, has named Alley, Clark & Greiwe partner Don Greiwe "Lawyer of the Year" for 2013 in Plaintiff’s Medical Malpractice Law in Tampa.  After more than a quarter of a century in publication, Best Lawyers is designating Lawyers of the Year in high-profile legal specialties in large legal communities. Only a single lawyer in each specialty in each community is being honored as the Lawyer of the Year.

Johnson & Johnson subsidiary DePuy Orthopaedics Inc. has recalled over 8,000 medical device units in response to the FDA finding that it sold the devices without the required approvals. The recall was disclosed on August 16, 2012, and is in response to a December letter where the FDA accused DePuy of marketing 14 various knee, hip, and ankle devices without proper approval.  DePuy tried to exercise a loophole saying the devices were customized to the needs of individual patients, but the FDA disagreed.  Despite receiving the warning in December, it took DePuy over 8 months to comply with the FDA request. 

Over the last few weeks, two extremely negative news reports were made regarding defibrillator leads manufactured by St. Jude Medical.  Leads are used to transmit electricity to the heart from a defibrillator which delivers a shock if it detects problems with a patient’s cardiac rhythm.  Last week, the FDA ordered St. Jude Medical to do more research on the safety of both its older Riata generation of leads as well as the new generation of Durata leads.  The FDA also made the rare move of recommending patients who had received the Riata leads to go undergo additional testing to determine whether the device will fail. 

Three lawyers from the Tampa-based personal injury law firm of Alley, Clark & Greiwe were recently selected by their peers for inclusion in The Best Lawyers in America® 2013 (Copyright 2010 by Woodward/White, Inc., of Aiken, S.C.).  Tampa Personal Injury Attorney C. Todd Alley was selected in the fields of Mass Tort Litigation and Personal Injury Litigation.  Tampa Medical Malpractice Attorney James D. Clark was selected in the fields of Medical Malpractice and Personal Injury Litigation.  Tampa Medical Malpractice Attorney Don Greiwe was selected in the field of Medical Malpractice law.

In late June 2012, a FDA Advisory Panel (consisting of orthopedic surgeons, medical experts, industry representatives, and patient advocates) convened a two day hearing to publically discuss safety data on metal-on-metal hip implants.

According to the Institute for Safe Medication Practices’ QuarterWatch, the FDA received more safety reports about Pradaxa (dabigatran) than any other drug in the year 2011.

In May of 2012, Health Canada issued a safety advisory warning to Canadian orthopedic surgeons regarding metal-on-metal hip implants.   The purpose of the advisory was to boost awareness in that country about significant health problems being reported in patients with metal-on-metal hip implants.